Latest News and Press Releases
Want to stay updated on the latest news?
-
HACKENSACK, N.J., Sept. 4, 2013 (GLOBE NEWSWIRE) -- Champions Oncology (OTC:CSBR), a company engaged in the development of advanced technology solutions and services to personalize the development and...
-
HACKENSACK, N.J., Sept. 3, 2013 (GLOBE NEWSWIRE) -- Champions Oncology (OTC:CSBR) announced today the addition of two members to its senior management team: Dr. Neal Goodwin, previously at Jackson...
-
HACKENSACK, N.J., June 10, 2013 (GLOBE NEWSWIRE) -- Champions Oncology, Inc. (OTC:CSBR), engaged in the development of advanced technology solutions and services to personalize the development and...
-
HACKENSACK, N.J., June 5, 2013 (GLOBE NEWSWIRE) -- Champions Oncology, Inc. (OTC:CSBR) today announced that it will report its fourth quarter and year-end financial results after market close on...
-
HACKENSACK, N.J., June 5, 2013 (GLOBE NEWSWIRE) -- Champions Oncology, Inc. (OTC:CSBR) is pleased to announce the oral presentation of a new paper, "Integrated Genomics and Avatar Mouse Models for...
-
HACKENSACK, N.J., April 4, 2013 (GLOBE NEWSWIRE) -- Champions Oncology, Inc. (OTC:CSBR) is pleased to announce that it will be presenting six posters on its Champions TumorGraft™ models and...
-
HACKENSACK, N.J., March 14, 2013 (GLOBE NEWSWIRE) -- Champions Oncology, Inc. (OTC:CSBR), engaged in the development of advanced technology solutions and services to personalize the development and...
-
HACKENSACK, N.J., March 8, 2013 (GLOBE NEWSWIRE) -- Champions Oncology, Inc. (OTC:CSBR) announced today that it will report its financial results for the third quarter, on Thursday, March 14, 2013 at...
-
HACKENSACK, N.J., March 5, 2013 (GLOBE NEWSWIRE) -- Champions Oncology, Inc. (OTC:CSBR) is pleased to announce the appointments of Dan Mendelson and Arthur G. ("Bart") Epker, III to the Board of...
-
HACKENSACK, N.J., Feb. 11, 2013 (GLOBE NEWSWIRE) -- Champions (OTC:CSBR) announced the successful completion of a TumorGraft technology collaboration with a subsidiary of Teva Pharmaceutical...